Faculty

Institution

Unit

Venue

Robyn Scherber

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Department Of Medicine

Department of Medicine

Division of Hematology & Medical Oncology

Department Of Medicine

Hematology and Medical Oncology

Oregon Health & Science University

NoneRobyn Scherber is currently serving as a Medicine faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robyn Scherber

Oregon Health & Science University

You can click a keyword to filter the displayed items

hematology medicine oncology hematological malignancies leukemia immunology myeloid neoplasia thrombosis myeloproliferative neoplasms cancer research quality of life clinical research malignant blood disorders bone marrow transplantation cancer care urology vascular biology pathology medicinal research lymphoid neoplasia disease assessment survival analysis clinical transplantation polycythemia vera hemostasis clinical immunology symptom burden indolent systemic mastocytosis inflammation myelopoiesis symptomatic treatment pharmacotherapy oncogenes essential thrombocythemia cancer immunotherapy cancer discovery cellular therapy surgical oncology gynecologic oncology fibrosis clinical case presentation clinical evidence cohort studies thrombotic events venous thrombosis mast cell disorders myeloproliferative neoplasm patients clinical rheumatology prognosis host factors bone marrow failure prognostic evaluation cancer biology bleeding disorders stem cell transplantation disease progression polycythemia vera patients thoracic oncology clinical microbiology inflammatory diseases blood transfusion bronchial neoplasm polytrauma cancer treatment laboratory hematology bone disease novel therapies patient experience disease evolution persistent leukocytosis overall survival total symptom score international prospective validation reliability trial et intolerant critical role

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessing Real-World Natural History of Indolent Systemic Mastocytosis: A Retrospective Matched Cohort Study. Journal of Allergy and Clinical Immunology Global (2026)

immunologyallergyimmune responsesimmunity (medicine)mast cell disorderspediatric allergy

A Systematic Literature Review of Avapritinib Outcomes in Patients With Indolent Systemic Mastocytosis. Journal of Allergy and Clinical Immunology (2026)

immunologyallergyautoimmune diseasesmast cell disorderspediatric allergyhypersensitivity

Assessing Real-World Natural History of Indolent Systemic Mastocytosis: Retrospective Matched Cohort Study From Mayo Clinic Electronic Health Records. Journal of Allergy and Clinical Immunology (2025)

Thanai PongdeeDakota PowellTaylor WeisRobyn ScherberAllison SmitherK. PurushothamKatherine CarlsonPrerna SinghJamie LoNivedita RangarajanErin SullivanHannah Barman

retrospective cohort studiesindolent systemic mastocytosisimmunologyreal-world natural historyallergyclinical immunology

HARBOR: An Ongoing Phase 2/3 Study of Elenestinib in Patients With Indolent Systemic Mastocytosis. Journal of Allergy and Clinical Immunology (2025)

Mariana CastellsCristina Bulai LivideanuOlivier HermineVito SabatoMarcus MaurerFranziska RuëffStephane BareteLaurence BouilletJens PanseIvan Twose-AlvarezDavid González-De-OlanoRenata CabralRobert BirdKarin HartmannT.J. RegoKevin HeJavier Muñoz-GonzálezRobyn ScherberTsewang TashiMar Guilarte

allergyimmunologyclinical immunologyindolent systemic mastocytosis

Figure 2 From the Nutrient Trial (Nutritional Intervention Among Myeloproliferative Neoplasms): Results From a Randomized Phase I Pilot Study for Feasibility and Adherence. (2024)

Laura F. Mendez LuqueJulio Avelar-BarraganHellen NguyenJenny NguyenEli M. SoyferJiarui LiuJane H. ChenNitya MehrotraXin HuangHeidi E. KosiorekAmylou DueckAlexander HimsteadElena HeideMelinda LemKenza El AlaouiEduard MasRobyn M. ScherberRuben A. MesaKatrine L. WhitesonAndrew OdegaardAngela G. Fleischman

nutritional interventionclinical trialsmyeloproliferative neoplasmshealth sciencesnutrient trial

Impact of Gender Representativeness in Online Symptom Survey and Clinical Trial Participation Among Patients With Myeloproliferative Neoplasms. Leukemia & lymphoma/Leukemia and lymphoma (2024)

Blake LanglaisAmylou C. DueckHeidi E. KosiorekCarolyn Mead-HarveyEric MeekLauren RogakJohn MascarenhasRuben MesaKrisstina GowinJean PalmerRobyn ScherberBridget MarcellinoRonald HoffmanGina L. Mazza

clinical trial participationmyeloproliferative neoplasmsleukemiaclinical trialsgender representativeness

Mediterranean Diet Education Materials From the Nutrient Trial (Nutritional Intervention Among Myeloproliferative Neoplasms): Results From a Randomized Phase I Pilot Study for Feasibility and Adherence. (2024)

medical nutritioneducationhuman nutritionnutritional interventioncancer researchdietary healthmedicinemyeloproliferative neoplasmsnutrient trialhealth sciencesoncology

Patient-Reported Outcome Measures in Systemic Mastocytosis: A Systematic Review. Journal of Allergy and Clinical Immunology (2024)

Cem AkinErin SullivanMaria RocheRobyn ScherberDakota PowellTeresa GreenFrank Siebenhaar

systematic reviewimmunologymedicinal researchclinical allergyhematologydermatologyallergyoutcomes researchpatient-reported outcomesclinical immunologysystemic mastocytosis

Translation, Cultural Adaptation, and Validation Into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form—Total Symptom Score (Mpn-Saf Tss or Mpn-10) Questionnaire. Journal of Clinical Medicine (2024)

Mihnea-Alexandru GămanRobyn Marie ScherberIulia UrsuleacAna Manuela CrişanSorina Nicoleta BădeliţăBogdan Octavian IonescuAlexandra Elena GhiaurMelen BrînzăNicoleta PîrciulescuToma Octavian LascărCamelia Cristina DiaconuAmelia Maria GămanDaniel Coriu

pathologyclinical medicineclinical translationdisease assessmentmyeloid neoplasiainfectious diseasestumor biologylanguage assessmentcancer researchjama oncologytotal symptom scorempn-saf tssdisease diagnosisclinical rheumatologyneurologyworld psychiatrycultural adaptationdiagnosisclinical researchleukemiaoncology

Avapritinib Improved Skin Findings in Patients With Indolent Systemic Mastocytosis in the Registrational, Double-Blind, Placebo Controlled Pioneer Study. (2023)

Karin HartmannMARCUS MAURERFrank SiebenhaarSigurd Broesby-OlsenTracy I. GeorgeCristina Bulai LivideanuIván Alvarez-TwoseJens PanseStéphane BareteAndreas ReiterIngunn DybedalCem AkinPaul Van DaeleDeepti H. RadiaSonia CerquozziCelalettin UstunVito SabatoJason GotlibMark RaffertyDaniel J. DeAngeloPrincess U. OgboguScott FlorellDavid WadaAnton RetsHui-Min LinJanet HongTeresa GreenRobyn ScherberMaria RocheMariana Castells

dermatologyskin findingspharmacologyuneven developmentclinical immunologycase studiesvascular biologybenchmark studieswound healingpharmacotherapynanomedicinemedicinal researchpilot experimentcellular therapystrokeindolent systemic mastocytosisinflammationrheumatologypioneer studymedicineclinical transplantation

1
2
3
4
5
12
10 / page

Robyn Scherber

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Department Of Medicine

Department of Medicine

Division of Hematology & Medical Oncology

Department Of Medicine

Hematology and Medical Oncology

Oregon Health & Science University

NoneRobyn Scherber is currently serving as a Medicine faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robyn Scherber

Oregon Health & Science University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessing Real-World Natural History of Indolent Systemic Mastocytosis: A Retrospective Matched Cohort Study. Journal of Allergy and Clinical Immunology Global (2026)

immunologyallergyimmune responsesimmunity (medicine)mast cell disorderspediatric allergy

A Systematic Literature Review of Avapritinib Outcomes in Patients With Indolent Systemic Mastocytosis. Journal of Allergy and Clinical Immunology (2026)

immunologyallergyautoimmune diseasesmast cell disorderspediatric allergyhypersensitivity

Thanai PongdeeDakota PowellTaylor WeisRobyn ScherberAllison SmitherK. PurushothamKatherine CarlsonPrerna SinghJamie LoNivedita RangarajanErin SullivanHannah Barman

retrospective cohort studiesindolent systemic mastocytosisimmunologyreal-world natural historyallergyclinical immunology

HARBOR: An Ongoing Phase 2/3 Study of Elenestinib in Patients With Indolent Systemic Mastocytosis. Journal of Allergy and Clinical Immunology (2025)

allergyimmunologyclinical immunologyindolent systemic mastocytosis

Figure 2 From the Nutrient Trial (Nutritional Intervention Among Myeloproliferative Neoplasms): Results From a Randomized Phase I Pilot Study for Feasibility and Adherence. (2024)

nutritional interventionclinical trialsmyeloproliferative neoplasmshealth sciencesnutrient trial

Impact of Gender Representativeness in Online Symptom Survey and Clinical Trial Participation Among Patients With Myeloproliferative Neoplasms. Leukemia & lymphoma/Leukemia and lymphoma (2024)

Blake LanglaisAmylou C. DueckHeidi E. KosiorekCarolyn Mead-HarveyEric MeekLauren RogakJohn MascarenhasRuben MesaKrisstina GowinJean PalmerRobyn ScherberBridget MarcellinoRonald HoffmanGina L. Mazza

clinical trial participationmyeloproliferative neoplasmsleukemiaclinical trialsgender representativeness

medical nutritioneducationhuman nutritionnutritional interventioncancer researchdietary healthmedicinemyeloproliferative neoplasmsnutrient trialhealth sciencesoncology

Patient-Reported Outcome Measures in Systemic Mastocytosis: A Systematic Review. Journal of Allergy and Clinical Immunology (2024)

Cem AkinErin SullivanMaria RocheRobyn ScherberDakota PowellTeresa GreenFrank Siebenhaar

systematic reviewimmunologymedicinal researchclinical allergyhematologydermatologyallergyoutcomes researchpatient-reported outcomesclinical immunologysystemic mastocytosis

Avapritinib Improved Skin Findings in Patients With Indolent Systemic Mastocytosis in the Registrational, Double-Blind, Placebo Controlled Pioneer Study. (2023)

1
2
3
4
5
12
10 / page